Zynex, Inc. Earnings Recaps
Q3 2025
Nov 18, 2025
Zynex, Inc. reported a challenging third quarter for 2025 marked by significant management changes and strategic pivots aimed at addressing compliance issues and improving financial stability.
Key takeaways
- Newly appointed management is focused on compliance, governance, and strategic marketing to turn the company around.
- A proactive resupply order fulfillment policy has led to increased patient engagement and improved customer experience.
- The company faces liquidity challenges with $60 million in convertible senior notes maturing in May 2026, necessitating urgent capital raising efforts.
- Initial signs of stabilization in customer order volumes have been observed despite a reduced sales force, supported by revamped commission plans and focused sales strategies.